DIFFERENTIAL TENOFOVIR ALAFENAMIDE (TAF) ADOPTION IN HBV-INFECTED POPULATIONS; ASSESSMENT OF CARE IN US CLINICAL PRACTICE Curry, M. P., Bae, H. S., Dieterich, D. T., Ankoma-Sey, V., Reddy, K., Pan, C. Q., Hann, H. L., Tong, M. J., Kim, W., Kwo, P., Frazier, L., Cox, K., Milligan, S., Afdhal, N. H. WILEY. 2019: 308A–309A

View details for Web of Science ID 000488653501052